Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gyre Therapeutics, Inc. - Common Stock (NQ: GYRE ) 12.54 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Gyre Therapeutics, Inc. - Common Stock < Previous 1 2 Next > Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday September 18, 2024 Via Benzinga Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday August 26, 2024 Via Benzinga GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024 August 13, 2024 Gyre Therapeutics just reported results for the second quarter of 2024. Via InvestorPlace GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q1 2024 May 09, 2024 Gyre Therapeutics just reported results for the first quarter of 2024. Via InvestorPlace Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update August 13, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics to Present at Sidoti Virtual Investor Conference August 09, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors August 08, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia July 02, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology June 18, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership June 01, 2024 Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in... Via Talk Markets Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension May 30, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 29, 2024 Via Benzinga Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday May 29, 2024 Via Benzinga Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes May 28, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session May 24, 2024 Via Benzinga Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire 7 A-Rated Aggressive Biotech Stocks to Bet On in 2024 April 12, 2024 We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades. Via InvestorPlace Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 11, 2024 Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. Via Benzinga Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday April 11, 2024 U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. Via Benzinga Topics Stocks Exposures US Equities Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update March 26, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum March 21, 2024 From Gyre Therapeutics, Inc. Via GlobeNewswire Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 29, 2024 Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session February 29, 2024 Via Benzinga Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session February 23, 2024 Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session February 23, 2024 Via Benzinga Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday February 23, 2024 U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday. Via Benzinga Topics Stocks Exposures US Equities Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday February 16, 2024 U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday. Via Benzinga Topics Stocks Exposures US Equities Is It Time to Buy the Nasdaq's 5 Worst-Performing Stocks in February 2024? February 07, 2024 Some Nasdaq stocks are soaring in 2024, but these five charts are down by 40% or more. Are any of these struggling stocks actually good buys at a low price? Via The Motley Fool Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 24, 2024 Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares... Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.